Saffron Walden, United Kingdom

Gareth William Langley

This inventor holds 1 USPTO granted patent. Top assignee: Neophore Limited. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gareth William Langley: Innovator in Isoindoline Derivatives

Introduction

Gareth William Langley is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of chemistry, particularly in the development of novel probe compounds. His work focuses on isoindoline derivatives that have important applications in biological research.

Latest Patents

Gareth holds a patent for isoindoline derivatives which bind to an ATP binding site. The present invention relates to novel probe compounds of formulae I and II defined herein. It also encompasses methods of synthesizing these novel probe compounds and their use in assays and screens for determining the binding of a test molecule to the ATP-binding site of a target protein. This includes proteins such as the Mismatch Repair (MMR) component proteins PMS2 and MLH1, and it aids in determining the location and/or quantity of such target proteins in a biological sample. He has 1 patent to his name.

Career Highlights

Gareth is associated with Neophore Limited, where he continues to advance his research and development efforts. His work has implications for understanding various biological processes and could lead to significant advancements in therapeutic applications.

Collaborations

Some of his notable coworkers include Julian Blagg and Paul Colin Michael Winship. Their collaborative efforts contribute to the innovative environment at Neophore Limited.

Conclusion

Gareth William Langley is a distinguished inventor whose work on isoindoline derivatives showcases his commitment to advancing scientific knowledge and applications. His contributions are valuable to the field of chemistry and biological research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…